A calcipotriol/hydrocortisone combination ointment has been developed for treating psoriasis on sensitive skin areas such as the face. The efficacy and safety of two calcipotriol/hydrocortisone dose combinations were compared with two concentrations of calcipotriol in the same ointment vehicle in patients with psoriasis on the face and body. Patients were randomised to receive 8 weeks once daily treatment with calcipotriol 25 mcg/g or 50 mcg/g, either alone or combined with hydrocortisone 10 mg/g. On the body and face overall, no statistically significant differences in efficacy were observed between the calcipotriol/hydrocortisone formulations versus the calcipotriol alone formulations nor between the two concentrations of calcipotriol (50 mcg/g versus 25 mcg/g). On the face alone, calcipotriol/hydrocortisone was significantly more effective than calcipotriol alone (P < 0.001) but no consistent significant difference was found between the two concentrations of calcipotriol. There was a significant benefit of combining hydrocortisone with calcipotriol in the incidence of adverse drug reactions on the body and face (P = 0.006) and on the face (P < 0.001) but no significant difference was found between the two concentrations of calcipotriol either on the body and face or on the face. In facial psoriasis, combining hydrocortisone with calcipotriol resulted in an improved efficacy and tolerability compared to calcipotriol alone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1684/ejd.2010.1013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis.
ACS Pharmacol Transl Sci
September 2024
Department of Pharmacology, College of Pharmacy, Al-Esraa University, Baghdad +964, Iraq.
Psoriasis is a chronic, inflammatory dermatosis characterized by thickened, reddened, and scaly skin lesions. Norfloxacin is a fluoroquinolone antibiotic with enhanced antioxidant, anti-inflammatory, and immunomodulatory bioactivities. The aim of this study was to figure out the possible impact of topical norfloxacin on an imiquimod-induced model of psoriasis in mice.
View Article and Find Full Text PDF1,25(OH)D and its analogue calcipotriol inhibit the migration of human synovial and mesenchymal stromal cells in a wound healing model - A comparison with glucocorticoids.
J Steroid Biochem Mol Biol
October 2023
Research Unit of Translational Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, P.O.Box 5000, FI-90014 Oulu, Finland; Division of Operative Care, Oulu University Hospital and University of Oulu, Finland.
Vitamin D analogue calcipotriol is currently used in the local treatment of psoriasis. However, it also has antiproliferative and anti-inflammatory effects in the cells of the joint - suggesting a possible benefit in local treatment of arthritis. In this study, calcipotriol was studied in different in vitro methods to find out its effect on synovial and mesenchymal stromal cells.
View Article and Find Full Text PDFEnhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology.
Dermatol Ther (Heidelb)
August 2023
MC2 Therapeutics, Hørsholm, Denmark.
Introduction: Effective topical drug delivery is the essence of dermatologic treatment. The drug must be applied to the skin surface, be released from the vehicle, enter the stratum corneum, traverse the epidermis, and enter the dermis pharmacologically intact. New advances have improved emulsion-type formulation and drug delivery technology by encapsulating dispersed oil droplets in a robust multimolecular aqueous film of surfactants, oil, and water, enabling a multifold decrease in surfactant concentration compared to conventional creams.
View Article and Find Full Text PDFThe Effect of Biological Treatment on Stress Parameters Determined in Saliva in Patients with Severe Psoriasis.
Medicina (Kaunas)
March 2023
Clinical Department of Internal Diseases, Dermatology and Allergology in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Article Synopsis
- Stress is a major factor that worsens psoriasis, but diagnosing it effectively in patients can be challenging, prompting research into saliva as a potential source of stress biomarkers.
- The study involved 104 adults with severe psoriasis, divided into groups receiving either biological treatment (adalimumab) or symptomatic therapy (calcipotriol/betamethasone gel), monitored through clinical assessments and saliva samples.
- Results indicated significant improvement in the biological treatment group, with notable changes in saliva biomarkers; sIgA levels increased consistently in the treatment group while sAA levels changed significantly in both groups, and CgA levels decreased in the treatment group only.
Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression.
Dig Dis Sci
July 2023
Department of Gastroenterology, Hepatology, and Nutrition, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Background: Pancreatic ductal adenocarcinoma (PDA) has a poor prognosis due to its therapeutic resistance. Inactivation of vitamin D/vitamin D receptor (VDR) signaling may contribute to the malignant phenotype of PDA and altered expression of oncoprotein mucin 1 (MUC1) may be involved in drug resistance of cancer cells.
Aim: To determine whether vitamin D/VDR signaling regulates the expression and function of MUC1 and its effect on acquired gemcitabine resistance of pancreatic cancer cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!